Loading…
The agreement is with Streeterville Capital.
Vivos Therapeutics, Inc. (Nasdaq: VVOS) announced a binding agreement for a senior debt-to-equity exchange of up to $4.5 million from Streeterville Capital. The transaction is expected to strengthen the company's financial position.
The agreement allows for the conversion of existing debt into equity, providing Vivos Therapeutics with additional capital. The exact terms and timing of the exchange will be detailed in forthcoming filings.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.